ACP
Altitude Crest Partners Portfolio holdings
AUM
$234M
This Quarter Return
+12.17%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$149M
AUM Growth
–
Cap. Flow
+$149M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
99.58%
Holding
12
New
12
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Legend Biotech
LEGN
|
$32.6M |
| 2 |
BridgeBio Pharma
BBIO
|
$30.5M |
| 3 |
Danaher
DHR
|
$28.1M |
| 4 |
argenx
ARGX
|
$11.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$11M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Legend Biotech
LEGN
$6.32B
| $32.6M | 21.82% |
+541,816
| New | +$32.6M |
|
|
2
BridgeBio Pharma
BBIO
$9.56B
| $30.5M | 20.38% |
+754,560
| New | +$30.5M |
|
|
3
Danaher
DHR
$146B
| $28.1M | 18.82% |
+121,600
| New | +$28.1M |
|
|
4
argenx
ARGX
$43.2B
| $11.2M | 7.51% |
+29,500
| New | +$11.2M |
|
|
5
BioMarin Pharmaceuticals
BMRN
$11.3B
| $11M | 7.36% |
+114,042
| New | +$11M |
|
6
Apellis Pharmaceuticals
APLS
$3.56B
| $9.11M | 6.1% |
+152,200
| New | +$9.11M |
|
7
Roivant Sciences
ROIV
$8.46B
| $9.07M | 6.07% |
+808,061
| New | +$9.07M |
|
8
Kiniksa Pharmaceuticals
KNSA
$2.54B
| $8M | 5.35% |
+456,041
| New | +$8M |
|
9
Exact Sciences
EXAS
$9.09B
| $7.33M | 4.91% |
+99,130
| New | +$7.33M |
|
10
Aligos Therapeutics
ALGS
$73.8M
| $1.89M | 1.26% |
+2,844,681
| New | +$1.89M |
|
|
AMAM
11
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $614K | 0.41% |
+43,100
| New | +$614K |
|
12
Surrozen, Inc. Warrant
SRZNW
$71.9K
| $7.69K | 0.01% |
+384,573
| New | +$7.69K |
|